ArticleSurgery today2026
Predictors and characteristics of late recurrence in non-small cell lung cancer patients 5 years or more after complete resection.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMost cases of postoperative non-small-cell lung cancer (NSCLC) recurrence occur within 5 years of curative resection, with rare cases of late recurrence occurring after 5 years. However, the unique characteristics of late recurrence remain unclear. This study aimed to elucidate the characteristics and risk factors for late recurrence in patients with NSCLC.
methodsWe retrospectively analyzed 693 patients who underwent curative resection for NSCLC between 2004 and 2013. The primary endpoint was the identification of risk factors for late recurrence, that is, recurrence 5 years after resection.
resultsThe 5- and 10-year overall survival (OS) rates were 80.6% and 63.7%, respectively. Among the 435 patients who were recurrence-free for 5 years postoperatively, late recurrence occurred in 24(5.5%). A multivariate analysis identified age at resection (≥ 75 years) as a significant risk factor for late recurrence. Post-recurrence survival did not differ between patients with recurrence within five years and those with late recurrence.
conclusionsAge at resection (≥ 75 years) was a potential risk factor for late NSCLC recurrence. These patients require long-term follow-up and monitoring for up to five years after resection.
Indexed as
Identifiers
41324670What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.